Global Prosthetic Heart Valve Market is Growing at a Significant Rate in the Forecast Period 2018-2025

Global Prosthetic Heart Valve Market According to Data Bridge Market Research new Market report, “By Product Type (Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast is projected to reach USD 14.04 billion by 2025, at a CAGR of 13.4% during the forecast period of 2018 to 2025.

Access Full Report: https://databridgemarketresearch.com/reports/global-prosthetic-heart-valve-market/

Global Prosthetic Heart Valve Market

Prosthetic heart valve which is also called as artificial heart valve is implanted in the heart of a patient with valvular heart disease. At c certain stage when treatment of heart valve disease does not provide relief to the patient, then this surgery is recommended as the best way to repair the valve. In valve replacement surgery, carbon based mechanical valves and biological tissue valve are the types of valves that can be selected based on the condition. Various technological advancements are driving this market. For instance, in January 2016, On-X partnered with Fred Hoiberg, Head Coach of the NBA Chicago Bulls, and heartvalvesurgery.com to launch a new patient education campaign, designed to help people with heart valve problems learn more about their condition and treatment options. Tissue heart valves are harvested from pig heart valves and cow heart sac. The life of a tissue valve is 10 to 15 years. Advancements in technology and increasing prevalence of heart valve diseases. In the U.S., only about 2,000 hearts are available each year, while there are 3,000 people waiting for a new heart. While you wait for a new heart, your doctor may insert a ventricular assist device (VAD) to help your heart continue to function. Furthermore, in June 2017, Edwards Lifesciences Corporation received an approval for the first transcatheter heart valve named SAPIEN 3 from U.S. food and drug administration. This heart valve can be used in treatment of both aortic and mitral patients who are more exposed to subsequent open-heart surgery to replace their bio prosthetic valve.

Segmentation: Global Prosthetic Heart Valve Market

The global market for prosthetic heart value by the following sub-categories is presented

  • By Product Type
    • Transcatheter Heart Valve
    • Tissue Heart Valve
    • Mechanical Heart Valve
  • By Geography
    • North America
    • South America
    • Europe
    • Asia-Pacific
    • Middle East and Africa

FACTORS DRIVING GROWTH IN THE GLOBAL PROSTHETIC HEART VALVE MARKET

Increase in the prevalence of heart value disease and valvular heart disease:

The leading of death in U.S. is heart disease, killing more than 600,000 Americans each year. It was found that each year more than 5 million Americans are diagnosed with heart value disease.  Heart valve disease can occur in any single valve or a combination of the four valves, but diseases of the aortic and mitral valves are the most common. Calcific aortic stenosis is the most common cause of aortic stenosis. Around 1.5 million people in the United States suffer from aortic stenosis, out of which approximately 500,000 among this group of patients suffer from severe aortic stenosis that is an estimated 250,000 patients with severe aortic stenosis. Around 80,000-85,000 aortic valve replacement procedures are performed every year in the U.S.

Diseases of the heart valves constitute a major cause of cardiovascular morbidity and mortality worldwide with rheumatic heart disease being the dominant form of valvular heart disease in developing nations. rheumatoid arthritis can affect cardiovascular system, leading to a wide range of appearances that can remain clinically silent or lead to substantial morbidity and mortality. Out of every 100,000 people, 41 are diagnosed with rheumatoid arthritis every year. About 1.3 million Americans have rheumatoid arthritis. Women are more exposed to this disease. It starts between the age of 30-60 in women. The life risk for developing rheumatoid arthritis is is 3.6 percent for women and 1.7 percent for men.

Hence with the increase in disease conditions such as heart value disease and valvular heart disease the demand for prosthetic heart value is expected to surge in future.

Rise in prevalence of cardiac disorders:

According to center for disease control and prevention, coronary heart disease is the most common type of heart disease, killing about 366,000 people in 2015. In the United States, there is a case of heart attack in every 40 seconds. Every minute, more than one person in the United States dies from a heart disease-related event. It was found that heart disease costs the United States around USD 200 billion each year.

According to world health organization 17.7 million people die each year from cardio vascular disease, an estimated 31% of all deaths worldwide.

Therefore, with the increasing cases of cardiovascular disorder the chances of using prosthetic heart valve increases, hence expecting this market to show a consistent growth in future.

Some of the major market players in this market are Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Abbott, LivaNova PLC, Boston Scientific Corporation, JenaValve Technology, Inc, CryoLife, Inc, TTK HealthCare, Colibri Heart Valve, lepumedica, Braile Biomédica, Comed B.V., HLT, XELTIS, Meril Life Sciences Pvt. Ltd, Scranton Gillette Communications.

Browse Related Reports:      

Global Veterinary Chemistry Analyzer Market – By Product {Chemistry Analyzer, Glucometer, Consumables (Panel, Test Strip, Reagent)}; Application (Blood Chemistry Analysis, Urinalysis, Glucose Monitoring); Animal (Companion & Livestock); Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024.

https://databridgemarketresearch.com/reports/global-veterinary-chemistry-analyzer-market/

Global IV Equipment Market,By Process (Infusion Pump, Catheter, Solution and Blood Administration Set, Securement Device, Cannula, Stopcock, Needleless Connector); End User (Hospitals & Clinics, Homecare, Ambulatory Care Center); Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024.

https://databridgemarketresearch.com/reports/global-iv-equipment-market/

North America Home Healthcare Market By Product Type, End User, Country (U.S., Canada, Mexico)–Industry Trends and Forecast to 2024.

https://databridgemarketresearch.com/reports/north-america-home-healthcare-market/

Global Surgical Staplers Market, By Product Type (Manual, Powered),  Type (Disposable, Reusable), Applications (Abdominal, General Surgery, Cardiac, Thoracic, Orthopaedic, Haemorrhoids, and Others), End User (Hospitals, Ambulatory Surgical Center, Clinics), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)- Industry Trends and Forecast to 2024.

https://databridgemarketresearch.com/reports/global-surgical-staplers-market/

Choose License Type
  • 200
  • 300
BUY NOW ADD TO CART